Global Antihypertensives Market, By Drug (Diuretics, Angiotensin Converting Enzyme Inhibitors, Angiotensin Receptor Blockers, Beta-blockers, Vasodilators, Calcium Channel Blockers, Renin Inhibitors, Alpha-Blockers, Others), Condition (Primary Hypertension, Secondary Hypertension), Medication Type (Monotherapy, Combination Therapy, Fixed Dose Combinations), Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Others), End User (Hospitals, Clinics, Homecare), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Antihypertensives market is expected to reach USD 29.33 billion by 2028 witnessing market growth at a rate of 2.71% in the forecast period of 2021 to 2028. Increase in incidence rate of cardiovascular diseases, owing to changing demographics and rise in prevalence of stroke, diabetes, and hypertension which will help in boosting the growth of the market.
Hypertension is characterised as a long-term medical condition that is marked by high, persistently elevated blood pressure in the arteries. Antihypertensive medicine, also known as hypertension, is used to treat people suffering from elevated blood pressure. Hypertension, caused by severe problems such as heart attack, heart failure and dementia, is a major condition.
Increasing prevalence of geriatric population across the globe, rapid adoption and rise in demand for angiotensin receptor blockers, high disposable income of the patient population, increasing penetration of generic versions of drugs, growing number of initiatives by private and government organizations, change in lifestyle such as food habits are some of the major as well as vital factors which will likely to augment the growth of the antihypertensives market in the projected timeframe of 2021-2028. On the other hand, surging levels of investment in research and development activities along with launch of novel drug therapy with improved efficacy and safety, favourable funding by government and charitable trusts for stroke research, prevention which will further contribute by generating massive opportunities that will lead to the growth of the antihypertensives market in the above mentioned projected timeframe.
High cost of treatment along with side effects associated with the treatment which will likely to act as market restraints factor for the growth of the antihypertensives in the above mentioned projected timeframe. Rise in non-pharmacological therapy along with loss of patents which will become the biggest and foremost challenge for the growth of the market.
This antihypertensives market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the antihypertensives market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Antihypertensives Market Scope and Market Size
Antihypertensives market is segmented on the basis of drug, condition, medication type, distribution channel and end user. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- Based on drug, the antihypertensives market is segmented into diuretics, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, beta-blockers, vasodilators, calcium channel blockers, renin inhibitors, alpha-blockers, and others. Diuretics have been further segmented into thiazide diuretics, loop diuretics, and potassium-sparing diuretics. Beta-blockers have been further segmented into beta-1 selective, and intrinsic sympathomimetic.
- Based on condition, the antihypertensives market is segmented into primary hypertension, and secondary hypertension.
- On the basis of medication type, the antihypertensives market is segmented into monotherapy, combination therapy, and fixed dose combinations.
- Based on distribution channel, the antihypertensives market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others.
- Antihypertensives market is also segmented on the basis of end user is segmented into hospitals, clinics, and homecare.
Antihypertensives Market Country Level Analysis
Antihypertensives market is analysed and market size information is provided by country, drug, condition, medication type, distribution channel and end user as referenced above.
The countries covered in the antihypertensives market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).
North America dominates the antihypertensives market due to surge in incidence of hypertension and rise in geriatric population along with easy availability of antihypertensive drugs in the region while the Asia-Pacific region is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the increasing awareness among the people along with evolving life science industry in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Antihypertensives market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Antihypertensives Market Share Analysis
Antihypertensives market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to antihypertensives market.
The major players covered in the antihypertensives market report are Merck KGaA; Boehringer Ingelheim International GmbH.; Bayer AG; Pfizer Inc.; Takeda Pharmaceutical Company Limited.; AstraZeneca; DAIICHI SANKYO COMPANY, LIMITED.; sanofi-aventis U.S. LLC; Novartis Pharmaceuticals Corporation; Janssen Global Services, LLC; F. Hoffmann-La Roche Ltd; United Therapeutics Corporation; Sun Pharmaceutical Industries Ltd.; GlaxoSmithKline plc.; Abbott.; Gilead Sciences, Inc.; Lupin Pharmaceuticals, Inc; Eli Lilly and Company.; Hanmi Pharm.Co.,Ltd.; NIPPON SHINYAKU CO.,LTD.; among other domestic and global players. Antihypertensives market share data is available for global, North America, South America, Europe, Asia-Pacific (APAC) and Middle East and Africa (MEA) separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Customization Available : Global Antihypertensives Market
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.